BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2244666)

  • 1. Actinic keratoacanthoma. Speculations on the nature of the lesion and the role of cellular immunity in its evolution.
    Lawrence N; Reed RJ
    Am J Dermatopathol; 1990 Oct; 12(5):517-33. PubMed ID: 2244666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
    J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell and squamous cell carcinomas. Clinico-histological features.
    Annessi G; Baliva G
    Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues with keratoacanthoma, pseudoepitheliomatous hyperplasia and squamous cell carcinoma within tattoos: a clinical point of view.
    Kluger N
    J Cutan Pathol; 2010 Jul; 37(7):812-3. PubMed ID: 19614733
    [No Abstract]   [Full Text] [Related]  

  • 6. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
    Lee YS; Teh M
    Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
    Tan KB; Lee YS
    Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma: clinical and histopathologic features of regression.
    Ko CJ; McNiff JM; Bosenberg M; Choate KA
    J Am Acad Dermatol; 2012 Nov; 67(5):1008-12. PubMed ID: 22521202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoacanthoma occurring within the red dye of a tattoo.
    Kluger N; Minier-Thoumin C; Plantier F
    J Cutan Pathol; 2008 May; 35(5):504-7. PubMed ID: 17976209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible key role of granzyme B in keratoacanthoma regression.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I
    Med Hypotheses; 2006; 66(6):1129-32. PubMed ID: 16497444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidermoid carcinoma or keratoacanthoma?].
    Estruch R; Aguilera MT; Cardellach F; Palou J
    Med Clin (Barc); 1986 Oct; 87(11):477. PubMed ID: 3784650
    [No Abstract]   [Full Text] [Related]  

  • 15. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.
    Arnault JP; Wechsler J; Escudier B; Spatz A; Tomasic G; Sibaud V; Aractingi S; Grange JD; Poirier-Colame V; Malka D; Soria JC; Mateus C; Robert C
    J Clin Oncol; 2009 Aug; 27(23):e59-61. PubMed ID: 19597016
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of UV induced keratoacanthoma-like lesions in HRA/Skh-1 mice and their comparison with keratoacanthomas in man.
    Canfield PJ; Greenoak GE; Reeve VE; Gallagher CH
    Pathology; 1985 Oct; 17(4):613-6. PubMed ID: 2419826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogenesis and progression in ultraviolet light-induced tumors in hairless mice.
    Kligman LH; Kligman AM
    J Natl Cancer Inst; 1981 Dec; 67(6):1289-93. PubMed ID: 6947111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-epitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma occurring within tattoos: diagnostic issues.
    Kluger N; Plantier F
    J Am Acad Dermatol; 2007 Nov; 57(5):901-2. PubMed ID: 17939943
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic detection of markers of keratinocyte differentiation. Its use in neoplastic and preneoplastic lesions of skin.
    Kvedar JC; Fewkes J; Baden HP
    Arch Pathol Lab Med; 1986 Mar; 110(3):183-8. PubMed ID: 2418804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.